The extracellular matrix of the central nervous system: Chondroitin sulphate type proteoglycans and neural repair

被引:4
|
作者
Crespo-Santiago, D [1 ]
机构
[1] Univ Cantabria, Fac Med, Dept Anat & Biol Celular, E-39011 Santander, Spain
关键词
central nervous system; chondroitin sulphate; chondroitinase; extracellular matrix; proteoglycans; regeneration;
D O I
10.33588/rn.3809.2003493
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim. In this paper we present a review of the main features of the extracellular matrix (ECM) of the central nervous system (CNS). Development. Proteoglycans (PG) are glycoproteins, a very common type of protein in the ECM. Among the PG, the most abundant type is the hyalectan or lectican family. The PG is formed by two main components; a protein and a sugar chain, which that is termed glycosaminoglycan (GAG). These GAGs are polymers of two simple sugars. The hyalectan family has GAGs of the Chondroitin sulphate type (CS), and for this reason they are termed PG-CS. PG-CS are linked to the hyaluronic acid (HA) and other molecules of the ECM in order to form a three-dimensional network. This network has several important roles in the maintenance of the homeostasis of the CNS. Conclusions. Several hypotheses have been proposed to elucidate the failure of the CNS regeneration after an injury or in several pathologies. It has been suggested that PG-CS, which expression is up-regulated after CNS injury, may play some role in this process of inhibition of the CNS regeneration. Furthermore, we present an approach to the therapeutic potential of the CNS regeneration after the inactivation of the PG-CS up-regulation.
引用
收藏
页码:843 / 851
页数:9
相关论文
共 50 条
  • [1] Chondroitin sulphate proteoglycans: Extracellular matrix proteins that regulate immunity of the central nervous system
    Haylock-Jacobs, Sarah
    Keough, Michael B.
    Lau, Lorraine
    Yong, V. Wee
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (12) : 766 - 772
  • [2] Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury
    Properzi, F
    Asher, RA
    Fawcett, JW
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 335 - 336
  • [3] The emerging role of chondroitin sulphate proteoglycans (CSPGS) in controlling plasticity of the central nervous system
    Kwok, J.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 94 - 95
  • [4] Chondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair
    Siebert, Justin R.
    Steencken, Amanda Conta
    Osterhout, Donna J.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [5] Matrix Metalloproteinases, Neural Extracellular Matrix, and Central Nervous System Pathology
    De Luca, Ciro
    Papa, Michele
    [J]. MATRIX METALLOPROTEINASES AND TISSUE REMODELING IN HEALTH AND DISEASE: TARGET TISSUES AND THERAPY, 2017, 148 : 167 - 202
  • [6] The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system
    Galtrey, Clare M.
    Fawcett, James W.
    [J]. BRAIN RESEARCH REVIEWS, 2007, 54 (01) : 1 - 18
  • [7] Axonal growth inhibition by chondroitin sulfate proteoglycans in the central nervous system
    Emmanuel Diaz-Martinez, Nestor
    Velasco, Ivan
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2009, 61 (02): : 140 - 149
  • [8] Proteoglycans in the central nervous system: Role in development, neural repair, and Alzheimer's disease
    Cui, Hao
    Freeman, Craig
    Jacobson, Glenn A.
    Small, David H.
    [J]. IUBMB LIFE, 2013, 65 (02) : 108 - 120
  • [9] A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice
    Rolls, A
    Avidan, H
    Cahalon, L
    Schori, H
    Bakalash, S
    Litvak, V
    Lev, S
    Lider, O
    Schwartz, M
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (08) : 1973 - 1983
  • [10] Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system
    Dyck, Scott M.
    Karimi-Abdolrezaee, Soheila
    [J]. EXPERIMENTAL NEUROLOGY, 2015, 269 : 169 - 187